SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5.80 |
| Enterprise Value ($M) | -2.22 |
| Book Value ($M) | 7.49 |
| Book Value / Share | 1.09 |
| Price / Book | 0.77 |
| NCAV ($M) | 7.42 |
| NCAV / Share | 1.08 |
| Price / NCAV | 0.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.00 |
| Return on Assets (ROA) | -0.62 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.16 |
| Current Ratio | 10.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.24 |
| Assets | 8.31 |
| Liabilities | 0.81 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | 57.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 152,358 | 494,637 | 30.80 | |
| 53,297 | 355,769 | 14.98 | |
| 144,354 | 766,648 | 18.83 | |
| 955,988 | 3,311,691 | 28.87 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GYRE – Gyre Therapeutics, Inc. | HEPA – Hepion Pharmaceuticals, Inc. |
| HOOK – HOOKIPA Pharma Inc. | HRTX – Heron Therapeutics, Inc. |
| ICCC – ImmuCell Corporation |
Financial data and stock pages provided by
Fintel.io